ENDOCRINE NEOPLASMS (NONGASTRIN) OF THE PANCREAS

被引:21
作者
GOWER, WR
FABRI, PJ
机构
[1] Departments of Biochemistry, Pathology, Pathologyand Surgery, University of South Florida College of Medicine, Laboratory and Surgical Services, Haley Veterans Hospital, Tampa
来源
SEMINARS IN SURGICAL ONCOLOGY | 1990年 / 6卷 / 02期
关键词
APUDoma; gut hormone; islet cell tumor; pancreatic cancer;
D O I
10.1002/ssu.2980060208
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although neoplasms that produce gut regulatory peptides and amines can be found throughout the gastroenteropancreatic axis (excluding carci‐noids), the vast majority of these lesions are found within the pancreas. Recognition of the various clinical syndromes produced by the secretions of these tumors, the development of sensitive and specific radioimmu‐noassays for the elaborated peptides, and development of more effective localization techniques have contributed to earlier diagnosis and marked improvement in patient care. Treatment is directed toward medical management to correct the metabolic disturbances produced by the excessive amounts of gut regulatory peptides, followed by localization and extirpation of tumor. In the presence of unresectable tumor or metastases, palliative treatment directed at reducing peptide secretion or preventing its effects by surgery, chemotherapy, hormonal therapy, and hepatic‐artery embolization can produce long‐term remission of symptoms. Because the majority of these tumors are malignant, the ultimate goal in successful patient management is the early detection and surgical excision of the islet cell tumor before metastases occur. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:98 / 109
页数:12
相关论文
共 85 条
[1]  
Bayliss WM, Starling EH, The mechanisms of pancreatic secretion, The Journal of Physiology, 28, pp. 325-353, (1902)
[2]  
Nicholls AG, Simple adenoma of the pancreas arising from an island of Langerhans, J Med, 8, pp. 385-395, (1902)
[3]  
Feyrter F, Uber die these von peripheren endokrineu, Drusen Wiener Zeitschr Inn Med, 27, pp. 9-38, (1946)
[4]  
Pearse AGE, The diffuse neuroendocrine system and the APUD concept: Related “endocrine” peptides in brain, intestine, pituitary, placenta, and anuran cutaneous glands, Med Biol, 55, pp. 115-125, (1977)
[5]  
Pearse AGE, Common cytochemical and ultrastructural characteristics of cell producing polypeptide hormones (the APUD series) and their relevance to thyroid ultimobranchial C cells and calcitonin, Proc R Soc Lond [Biol], 170, pp. 71-80, (1968)
[6]  
Schmechel D, Marangos PJ, Brightman M, Neuron‐specific eno‐lase is a molecular marker for peripheral and central neuroendocrine cells, Nature, 276, pp. 834-836, (1978)
[7]  
Lloyd RV, Wilson BS, Specific endocrine tissue marker defined by a monoclonal antibody, Science, 222, pp. 628-630, (1983)
[8]  
Lloyd RV, Cano M, Rosa P, Et al., Widespread distribution of chromogranin A and secretogranin I (chromogranin B) in neuro‐endocrine cells and tumors, Am J Pathol, 130, pp. 296-304, (1988)
[9]  
Wiedenmann B, Franke WW, Kuhn C, Et al., Synaptophysin: A marker protein for neuroendocrine cell and neoplasms, Proc Natl Acad Sci USA, 83, pp. 3500-3504, (1986)
[10]  
Gazdar AF, Helman LJ, Israel MA, Et al., Expression of neuro‐endocrine cell markers L‐dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and non‐endocrine origin, Cancer Res, 48, pp. 4078-4082, (1988)